PubMed displayed almost 37,000 hits for the search term “cardiac surgery AND 2022.” As before, we used the PRISMA approach and selected relevant publications for a results-oriented summary. We focused on coronary and conventional valve surgery, their overlap with interventional alternatives, and briefly assessed surgery for aorta or terminal heart failure. In the field of coronary artery disease (CAD), key manuscripts addressed prognostic implications of invasive treatment options, classically compared modern interventions (percutaneous coronary intervention [PCI]) with surgery (coronary artery bypass grafting [CABG]), and addressed technical aspects of CABG. The general direction in 2022 confirms the superiority of CABG over PCI in patients with anatomically complex chronic CAD and supports an infarct-preventative effect as underlying mechanism. In addition, the relevance of proper surgical technique to achieve durable graft patency and the need for optimal medical treatment in CABG patients was impressively illustrated. In structural heart disease, the comparisons of interventional and surgical techniques have been characterized by prognostic and mechanistic investigations underscoring the need for durable treatment effects and reductions of valve-related complications. Early surgery for most valve pathologies appears to provide significant survival advantages, and two publications on the Ross operation prototypically illustrate an inverse association between long-term survival and valve-related complications. For surgical treatment of heart failure, the first xenotransplantation was certainly dominant, and in the aortic surgery field, innovations in arch surgery prevailed. This article summarizes publications perceived as important by us. It cannot be complete nor free of individual interpretation, but provides up-to-date information for decision-making and patient information.

PubMed 显示搜索词“心脏手术 AND 2022”的点击量接近 37,000 次。和之前一样，我们使用 PRISMA 方法并选择相关出版物进行结果导向的总结。我们重点关注冠状动脉和传统瓣膜手术、它们与介入替代方案的重叠，并简要评估了主动脉或终末心力衰竭的手术。在冠状动脉疾病 (CAD) 领域，主要手稿讨论了侵入性治疗方案的预后影响，经典地将现代干预措施（经皮冠状动脉介入治疗 [PCI]）与手术（冠状动脉旁路移植术 [CABG]）进行比较，并讨论了以下技术方面的问题：冠状动脉搭桥术。2022 年的总体方向证实了对于解剖结构复杂的慢性 CAD 患者，CABG 优于 PCI，并支持梗塞预防作用作为潜在机制。此外，还深刻地说明了正确的手术技术与实现持久移植物通畅的相关性以及 CABG 患者对最佳医疗治疗的需求。在结构性心脏病中，介入和手术技术的比较以预后和机制研究为特征，强调需要持久的治疗效果和减少瓣膜相关并发症。大多数瓣膜病变的早期手术似乎可以提供显着的生存优势，两篇关于罗斯手术的出版物典型地说明了长期生存与瓣膜相关并发症之间的负相关性。对于心力衰竭的手术治疗，首次异种移植无疑占据主导地位，而在主动脉手术领域，弓形手术的创新盛行。本文总结了我们认为重要的出版物。它不可能是完整的，也不能不受个人解释的影响，但可以提供用于决策和患者信息的最新信息。